The Global Genotyping Market is estimated to be valued at approximately USD 2.42 billion in 2023 and is expected to grow at a robust CAGR of 14.59% over the forecast period 2024-2032. Request To ...

Gene editing, once a theoretical ambition, has matured into a revolutionary frontier in biotechnology. Technologies like CRISPR-Cas9, TALENs, and Zinc Finger Nucleases (ZFNs) have unlocked ...

A study in the journal Nature explains how age reshapes the blood system. In both humans and mice, a few stem cells, or ...

ACMG Meeting, experts gathered to share breakthroughs in genetics. BioLogic Pharma Solutions stood out with new insights on ...

Regeneron Pharmaceuticals REGN has emerged as the successful bidder in the bankruptcy auction for most of the assets of 23andMe Holding Co., a prominent player in human genetics and biotechnology.

The fall of 23andMe raises privacy concerns as Regeneron buys its genetic database for $256M after bankruptcy.

Anjana Harve currently works at BJ's Wholesale Club Holdings, Inc., as Chief Information Officer & Executive VP from 2023, Tau Ventures LLC, as Advisor, and Wolters Kluwer NV, as Member-Supervisory ...

Medical records of hundreds of patients at a Sydney hospital's cancer genetics service have been reviewed following ...

POTOMAC, MD / ACCESS Newswire / May 12, 2025 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC" or the "Company") today announced that it presented its latest scientific poster, titled "Genetic Toxicity Ev ...

Myriad Genetics Inc. advanced stock charts by Barron's. View MYGN historical stock data and compare to other stocks, and exchanges.

Acupressure on the feet may promote relaxation and stress relief, among other benefits. Share on Pinterest Foot reflexology is a treatment that’s been practiced for centuries. It involves ...

Myriad Genetics MYGN underwent analysis by 11 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The table below provides a snapshot of their recent ratings ...